COVID 19: beta thalassemia subjects immunised?
Abstract The novel coronavirus pneumonia (COVID 19) is a contagious acute respiratory infectious disease whose causative agent has been demonstrated to be a novel virus of the coronavirus family, SARSCoV 2. A recent PRE print study has showed a heme attack on the 1 beta chain of hemoglobin by COVID19. Beta thalassemia results of a default in the hemoglobin beta chain synthesis. 1,5% global population are heterozygotes for this disease. In this study, by a multiple linear regression, we have analyzed the evolution of COVID 19 infection in three Italian regions (Puglia, Sardinia, Sicilia) with different beta thalassemic prevalences, in order to search a link. The results have showed that betathalassemic heterozygote population prevalence is correlated to immunity against COVID 19, by a regression. This paper is only for academic discussion, the hypotheses and conclusions needs to be confirmed by further research
Medical Hypotheses